Pfizer is trading 0.85% upper at Rs 4,159.35 as compared to its last closing price. Pfizer has been trading in the price range of 4,424.05 & 4,090.00. Pfizer has given -21.06% in this year & -5.57% in the last 5 days. Pfizer has TTM P/E ratio 39.26 as compared to the sector P/E of 25.53.There are 3 analysts who have initiated coverage on Pfizer. There are 2 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 127.60 Crores in its last quarter.Listed peers of Pfizer include Aurobindo Pharma (2.95%), Pfizer (0.85%), Astrazeneca Pharma India (-1.46%).The Mutual Fund holding in Pfizer was at 11.30% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Pfizer was at 2.74% in 31 Dec 2024. The FII holding has decreased from the last quarter.
Updated on Feb 14, 2025, 02:25 AM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Aurobindo Pharma | Neutral | 1,179.00 | 2.95 | 68,382.32 | 20.91 | 2.34 | 0.38 | 8.00 |
Pfizer | Bearish | 4,159.35 | 0.85 | 19,003.40 | 36.40 | 5.54 | 0.80 | 1.51 |
Astrazeneca Pharma India | Bullish | 7,385.00 | -1.46 | 18,392.63 | 126.60 | 26.73 | 0.32 | 0.39 |
Neuland Laboratories | Moderately Bearish | 12,702.50 | -7.00 | 16,285.80 | 57.42 | 14.25 | 0.10 | 4.22 |
Unichem Laboratories | Moderately Bearish | 694.20 | -0.43 | 4,897.45 | - | 2.17 | - | 2.64 |
Meeting Date | Purpose |
---|---|
2025-01-31 | Quarterly Results |
2024-10-28 | Quarterly Results |
2024-07-29 | Quarterly Results |
2024-05-17 | Audited Results & Final Dividend |
2024-02-09 | Quarterly Results |
Pfizer is trading at 4159.35 as on Thu Feb 13 2025 10:20:36. This is 0.85% upper as compared to its previous closing price of 4124.30.
The market capitalization of Pfizer is 19003.40 Cr as on Thu Feb 13 2025 10:20:36.
The average broker rating on Pfizer is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Pfizer is 6452.85 whereas the 52 wk low is 4012.65
Pfizer can be analyzed on the following key metrics -
Pfizer reported a net profit of 551.33 Cr in 2024.
The Mutual Fund Shareholding was 11.30% at the end of 31 Dec 2024.